These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 2282967
1. Development of clinically important resistance to quinolones and other antibiotic groups. Lode H. J Int Med Res; 1990; 18 Suppl 4():27D-36D. PubMed ID: 2282967 [Abstract] [Full Text] [Related]
2. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics]. Miyazakin S, Yamaguchi K. Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536 [No Abstract] [Full Text] [Related]
3. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates. Mascellino MT, Farinelli S, Iegri F, Iona E, De Simone C. Drugs Exp Clin Res; 1998 Jul; 24(3):139-51. PubMed ID: 9825230 [Abstract] [Full Text] [Related]
4. [Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins]. Ruczkowska J, Dolna I. Wiad Lek; 1989 May 01; 42(9):579-83. PubMed ID: 2629327 [Abstract] [Full Text] [Related]
5. [The extent of resistance on clinically important pathogens in the Federal Republic]. Pulverer G. Adv Clin Pharmacol; 1974 May 01; 8():21-32. PubMed ID: 4157112 [No Abstract] [Full Text] [Related]
6. [Resistance of gram-negative bacteria to beta-lactams, aminoglycosides and quinolones]. Schumacher H, Thomsen VF. Ugeskr Laeger; 1994 Oct 17; 156(42):6185-90. PubMed ID: 7998354 [Abstract] [Full Text] [Related]
7. Susceptibility of clinically important gram-negative bacilli to 15 antibiotics. Comparison of patterns in Poland and Federal Republic of Germany. Jeljaszewicz J, Pulverer G, Dajek Z, Stochmal I, Cybulska J, Hryniewicz W, Switalski LM, Dziarski R. Zentralbl Bakteriol Orig A; 1976 Aug 17; 235(4):459-75. PubMed ID: 824896 [Abstract] [Full Text] [Related]
8. Resistance to aminoglycosides: the situation in the Federal Republic of Germany. Naber KG, Grimm H, Rosenthal EJ, Shah PM, Wiedemann B. J Int Med Res; 1990 Aug 17; 18 Suppl 4():6D-26D. PubMed ID: 2178099 [Abstract] [Full Text] [Related]
9. [Phenotypes of resistance to antibiotics of the most frequently isolated strains in five specialized hospital centers. Multicenter study]. Gabastou JM, Chouaki T, Mangeot J, Zemir A, Manuel C, Lepitre M, Gravisse J, Cornel E, Denis-Jacquot N, Mahuzier G. Pathol Biol (Paris); 1995 Apr 17; 43(4):320-3. PubMed ID: 7567123 [Abstract] [Full Text] [Related]
10. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics. Watine J, Bourrel C, Dubourdieu B, Gineston JL, Bories P, Durand M, Marre A, Formosa F, Brunel MP, Palliez J. Pathol Biol (Paris); 1994 Apr 17; 42(4):293-5. PubMed ID: 7808781 [Abstract] [Full Text] [Related]
11. Comparative in-vitro activities of commonly available quinolones and other antibiotics on bacterial isolates in Ibadan, Nigeria. Oni AA, Bakare RA, Arowojolu AO, Kehinde Toki RA, Fasina NA. Afr J Med Med Sci; 2001 Apr 17; 30(1-2):35-7. PubMed ID: 14510147 [Abstract] [Full Text] [Related]
12. [Epidemiology of septicaemia pathogens]. Rosenthal EJ. Dtsch Med Wochenschr; 2002 Nov 15; 127(46):2435-40. PubMed ID: 12432483 [Abstract] [Full Text] [Related]
13. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin. Gilbert DN, Kohlhepp SJ, Slama KA, Grunkemeier G, Lewis G, Dworkin RJ, Slaughter SE, Leggett JE. Antimicrob Agents Chemother; 2001 Mar 15; 45(3):883-92. PubMed ID: 11181375 [Abstract] [Full Text] [Related]
14. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections]. Kowalska-Krochmal B, Dolna I, Dobosz A, Wrzyszcz E, Gościniak G. Med Dosw Mikrobiol; 2008 Mar 15; 60(3):205-14. PubMed ID: 19143174 [Abstract] [Full Text] [Related]
15. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections]. Mróz E, Jankowski S, Bartelmus J, Grzybek-Hryncewicz K, Ruczkowska J, Starek J, Boratyńska M. Med Dosw Mikrobiol; 1993 Mar 15; 45(1):115-8. PubMed ID: 8231429 [Abstract] [Full Text] [Related]
16. [Evolution of bacterial resistance to five aminoglycosides. A study of 3,354 strains isolated in a hospital milieu]. Fourche J, Texier-Maugein J, Mormede M. Pathol Biol (Paris); 1988 Jun 15; 36(5 Pt 2):665-70. PubMed ID: 3054744 [Abstract] [Full Text] [Related]
17. Polyamine effects on antibiotic susceptibility in bacteria. Kwon DH, Lu CD. Antimicrob Agents Chemother; 2007 Jun 15; 51(6):2070-7. PubMed ID: 17438056 [Abstract] [Full Text] [Related]
18. Cross-resistance between some aminoglycoside antibiotics. Onaolapo JA. Afr J Med Med Sci; 1994 Sep 15; 23(3):215-9. PubMed ID: 7604744 [Abstract] [Full Text] [Related]
19. In-vitro activity of quinolones against different species of staphylococci of recent clinical isolation. Rabagliati AM, Fiorio P, Cavallo R, Mills V, Penna R. J Chemother; 1991 Jan 15; 3 Suppl 1():176-8. PubMed ID: 12041759 [Abstract] [Full Text] [Related]
20. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use]. Jónsdóttir K, Kristinsson KG. Laeknabladid; 2008 Apr 15; 94(4):279-85. PubMed ID: 18460726 [Abstract] [Full Text] [Related] Page: [Next] [New Search]